Spanish pharmaceutical company Grifols has announced plans to appoint independent directors to its board, as revealed by the company's chairman in a recent interview with a leading newspaper.
The decision to bring in independent directors is seen as a strategic move by Grifols to enhance transparency and governance within the organization. By including individuals with diverse backgrounds and expertise, the company aims to benefit from fresh perspectives and insights that can contribute to its long-term growth and success.
